Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_assertion type Assertion NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_head.
- NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_assertion description "[G-CSF therapy did not increase the risk of t-MDS/AML development in children with aplastic anemia over a median follow-up of 3.7 years]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_provenance.
- NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_assertion evidence source_evidence_literature NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_provenance.
- NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_assertion SIO_000772 14607763 NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_provenance.
- NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_assertion wasDerivedFrom befree-2016 NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_provenance.
- NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_assertion wasGeneratedBy ECO_0000203 NP419930.RAcvI6o3-4_RGUbKGPuB3oglm6UsCG5ftIpRy7jf8v1gc130_provenance.